eClinical Tech News

Pyxis Oncology’s PYX-201, an antibody-drug conjugate targeting Extradomain-B Fibronectin (EDB+FN), received Fast Track Designation from the FDA for treating...

Quantum BioPharma Ltd. announced the successful completion of a Phase 1 clinical trial for Lucid-MS, a novel neuroprotective compound...

Regeneron Pharmaceuticals announced that the FDA accepted its resubmitted Biologics License Application (BLA) for odronextamab. The drug is intended...

Ligand Pharmaceuticals has invested $50 million and led a syndicate of co-investors, including Paragon Biosciences, Valor Equity Partners, and...

ORIC Pharmaceuticals announced focused development plans for its lead programs, ORIC-944 and ORIC-114, extending its cash runway into 2027....

Teva Pharmaceuticals and Medincell announced that the FDA accepted their supplemental New Drug Application for UZEDY, a long-acting injectable...

Elixirgen Therapeutics announced positive Phase 1/2 clinical trial data for EXG-34217, a novel therapy for Telomere Biology Disorders (TBDs)....

Trethera Corporation announced research published in Immunology demonstrating that their drug, TRE-515, effectively inhibits the hyperactive lymphocytes responsible for...

Femasys Inc. announced positive clinical trial data for FemBloc, a non-surgical permanent birth control method, published in the Journal...

Silexion Therapeutics (NASDAQ: SLXN) has completed data collection for its first study of SIL-204 in orthotopic pancreatic cancer models....